Spero Therapeutics Inc. 最新公布的财务数据显示,该公司第一季度运营支出为779.6万美元。与此同时,其运营亏损为753.8万美元。这一数据揭示了该生物技术公司在报告期内的财务运营状况。
Spero Therapeutics Inc. 最新公布的财务数据显示,该公司第一季度运营支出为779.6万美元。与此同时,其运营亏损为753.8万美元。这一数据揭示了该生物技术公司在报告期内的财务运营状况。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.